Literature DB >> 16172122

Catalytic degradation of vitamin D up-regulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia.

Guosheng Xiang1, Tetsunori Seki, Michael D Schuster, Piotr Witkowski, Andrew J Boyle, Fiona See, Timothy P Martens, Alfred Kocher, Hugo Sondermeijer, Henry Krum, Silviu Itescu.   

Abstract

Vitamin D3 up-regulated protein 1 (VDUP1) is a key mediator of oxidative stress on various cellular processes via downstream effects on apoptosis signaling kinase 1 (ASK1) and p38 mitogen-activated protein kinase (MAPK). Here, we report that VDUP1 expression is significantly increased in rat hearts following acute myocardial ischemia, suggesting it may have important regulatory effects on cardiac physiological processes during periods of oxidative stress. Transfection of H9C2 cardiomyoblasts with a sequence-specific VDUP1 DNA enzyme to down-regulate VDUP1 mRNA expression significantly reduced apoptosis and enhanced cell survival under conditions of H(2)O(2) stress, and these effects involved inhibition of ASK1 activity. Direct intracardiac injection of the DNA enzyme at the time of acute myocardial infarction reduced myocardial VDUP1 mRNA expression and resulted in prolonged reduction in cardiomyocyte apoptosis and ASK1 activity. Moreover, down-regulation of VDUP1 was accompanied by significant reduction in cardiac expression of pro-collagen type I alpha2 mRNA level, as well as marked reduction in myocardial scar formation. These features were accompanied by significant improvement in cardiac function. Together, these results suggest a direct role for VDUP1 in the adverse effects of ischemia and oxidative stress on cardiomyocyte survival, left ventricular collagen deposition, and cardiac function. Strategies to inhibit VDUP1 expression and/or function during acute ischemic events may be beneficial to cardiac functional recovery and prevention of left ventricular remodeling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16172122     DOI: 10.1074/jbc.M502966200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.

Authors:  Ravinay Bhindi; Roger G Fahmy; Harry C Lowe; Colin N Chesterman; Crispin R Dass; Murray J Cairns; Edward G Saravolac; Lun-Quan Sun; Levon M Khachigian
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

Review 2.  DNAzymes and cardiovascular disease.

Authors:  V L Benson; L M Khachigian; H C Lowe
Journal:  Br J Pharmacol       Date:  2008-05-05       Impact factor: 8.739

3.  Identification of an Anti-diabetic, Orally Available Small Molecule that Regulates TXNIP Expression and Glucagon Action.

Authors:  Lance A Thielen; Junqin Chen; Gu Jing; Omar Moukha-Chafiq; Guanlan Xu; SeongHo Jo; Truman B Grayson; Brian Lu; Peng Li; Corinne E Augelli-Szafran; Mark J Suto; Matt Kanke; Praveen Sethupathy; Jason K Kim; Anath Shalev
Journal:  Cell Metab       Date:  2020-07-28       Impact factor: 27.287

4.  Calcium channel blockers act through nuclear factor Y to control transcription of key cardiac genes.

Authors:  Hyunjoo Cha-Molstad; Guanlan Xu; Junqin Chen; Gu Jing; Martin E Young; John C Chatham; Anath Shalev
Journal:  Mol Pharmacol       Date:  2012-06-25       Impact factor: 4.436

5.  Deletion of thioredoxin-interacting protein in mice impairs mitochondrial function but protects the myocardium from ischemia-reperfusion injury.

Authors:  Jun Yoshioka; William A Chutkow; Samuel Lee; Jae Bum Kim; Jie Yan; Rong Tian; Merry L Lindsey; Edward P Feener; Christine E Seidman; Jonathan G Seidman; Richard T Lee
Journal:  J Clin Invest       Date:  2011-12-27       Impact factor: 14.808

Review 6.  Thioredoxin in the cardiovascular system.

Authors:  Cameron J World; Hideyuki Yamawaki; Bradford C Berk
Journal:  J Mol Med (Berl)       Date:  2006-10-05       Impact factor: 4.599

Review 7.  Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance.

Authors:  Samuel Lee; Soo Min Kim; Richard T Lee
Journal:  Antioxid Redox Signal       Date:  2012-06-26       Impact factor: 8.401

Review 8.  Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms.

Authors:  Oded N Spindel; Cameron World; Bradford C Berk
Journal:  Antioxid Redox Signal       Date:  2011-12-20       Impact factor: 8.401

9.  A novel role of myosin VI in human prostate cancer.

Authors:  Thomas A Dunn; Shenglin Chen; Dennis A Faith; Jessica L Hicks; Elizabeth A Platz; Yidong Chen; Charles M Ewing; Jurga Sauvageot; William B Isaacs; Angelo M De Marzo; Jun Luo
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

10.  A bimodal association of vitamin D levels and vascular disease in children on dialysis.

Authors:  Rukshana Shroff; Martyn Egerton; Michala Bridel; Vanita Shah; Ann E Donald; Tim J Cole; Melanie P Hiorns; John E Deanfield; Lesley Rees
Journal:  J Am Soc Nephrol       Date:  2008-03-12       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.